The above results indicated the unfavorable survival outcomes of the high-risk group might be relative to tumor progression and the favorable survival outcomes of the group of lower risk scores may be associated with higher infiltration levels of CD8 T cell and other antitumor immune cells. This evidence concerns the gene CD8A and neoplasm.